期刊文献+

MUC1对人结肠癌细胞HCT116生物学行为的影响

Effect of MUC1 on Biological Behaviour of Human Colorectal Cancer Cell HCT116
原文传递
导出
摘要 目的:观察MUC1对人结肠癌细胞HCT116增殖、侵袭及化疗敏感性的影响。方法:采用MUC1表达阴性的结肠癌细胞株HCT116,通过慢病毒转染、嘌呤霉素筛选、半定量RT-PCR和Western blot鉴定构建稳定表达MUC1的HCT116细胞株;实验分空病毒组和MUC1病毒组;CCK实验和软琼脂克隆形成实验检测两组细胞的增殖能力,Transwell侵袭实验检测两组细胞的侵袭能力;MTT法和流式细胞仪检测两组细胞对奥沙利铂的敏感性,酶底物法检测Caspase-3活性。结果:获得稳定表达MUC1的HCT116细胞株;两组细胞贴壁生长无差异;与空病毒组相比,MUC1病毒组细胞软克隆形成数增加,穿过小室的细胞数增加(P<0.05);MUC1病毒组细胞对奥沙利铂的敏感性降低,MUC1病毒组Caspase-3活性水平低于空病毒组(P<0.05)。结论:MUC1与结肠癌的非锚定依赖生长、侵袭和化疗敏感性有关。 Objective: To investigate the effect of MUC1 on proliferation,invasion and chemosensitivity of human colorectal cancer cell line HCT116. Methods: The HCT116 human colon cancer cells were transfected with lentiviral vectors with and without MUC1,then selected by puromycin. The expression of MUC1 was detected by SqRT-PCR and Western blot. There were two groups in our experiment: MUC1 lentivirus group and control lentivirus group. CCK method and soft agar colony formation method were used to detect cells proliferation,Transwell membrane assay to detect cells invasion,MTT method and flow cytometry to detect cells sensitivity to oxaliplatin and the colorimetric method to detect Caspase-3 activity. Results: HCT116 cell line with stable expression of the MUC1 was acquired. Compared with control lentivirus group,the number of soft agar colonies in MUC1 lentivirus group was increased significantly( P 〈 0. 05),the number of invasive cells was increased significantly( P 〈 0. 05). Chemosensitivity was decreased in the MUC1 lentivirus group( P 〈 0. 05).Caspase-3 activity was significantly low in the MUC1 lentivirus group( P 〈 0. 05). Conclusion: MUC1 is related to the anchorage-independent growth,invasion and chemotherapy of colorectal cancer.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2015年第1期15-20,共6页 China Biotechnology
基金 国家自然科学基金(81172262) 重庆市科委项目(2011BB5120)资助项目
关键词 MUC1 结肠癌 增殖 侵袭 化疗敏感性 MUC1 Colorectal cancer Proliferation Invasion Chemotherapy sensitivity
  • 相关文献

参考文献20

  • 1Jemal A, Bray F, Center M M, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61 (2) :69-90.
  • 2Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin, 2012, 62 (4): 220-241.
  • 3Shimizu M, Yamauchi K. Isolation and characterization of mucin- like glycoprotein in human milk fat globule membrane. J Biochem, 1982, 91 (2) :515-524.
  • 4Nath S, Mukherjee P. MUCI: a muhifaceted oncoprotein with a key role in cancer progression. Trends Mol Med, 2014, 20(6) : 332-342.
  • 5Kufe D W. MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches. Oncogene, 2013, 32 (9) : 1073-1081.
  • 6Tamada Y, Takeuchi H, Suzuki N, et al. Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary. Cancer Sei, 2007, 98 (10) : 1586- 1591.
  • 7Li Y Q, Liu D, Cben D S, et al. Human DF3/MUC1 carcinoma- associated protein functions as an oncogene. Oncogene, 2003,22 (38) :6107-6110.
  • 8Horm T M, Schroeder J A. MUC1 and metastatic cancer expression, function and therapeutic targeting. Cell Adbes Migr, 2013, 7(2) :187-198.
  • 9Horn G, Gaziel A, Wreschner D H, et al. ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1. Exp Cell Res, 2009, 315(8) :1490-1504.
  • 10Chen J S, Wang Q, Fu X H, et al. Involvement of PI3K/PTEN/ AKT/mTOR pathway in invasion and metastasis in hepatoccllular carcinoma: Association with MMP-9. Hepatol Res, 2009, 39 (2) :177-186.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部